Maxx Chatsko

BioMap is a media company founded in 2018 by Isaac Larkin, Christopher Norys, and Maxx Chatsko. Founded as a public benefit company, the platform has stated aims to 'build and encourage a more open and distributed biotech sector through creative projects, independent analysis, data tools, and partnerships.'

BioMap is a new media company (versus "old media") founded in 2018 by Isaac Larkin, Christopher Norys, and Maxx Chatsko. Founded as a public benefit company, the platform has stated aims to 'build and encourage a more open and distributed biotech sector through creative projects, independent analysis, data tools, and partnerships.'

BioMap is a new media company (versus "old media") founded in 2018 by Maxx Chatsko and Isaac Larkin. It publishes independent content in the form of articles, hosts open databases covering topics in the global biotech sector, and creates and supports projects focused on open source biology and distributed biology. BioMap was established as a public benefit company.

BioMap develops, organizes, and maintains databases comprising information on specific topics in the global biotechnology sector. Databases provide raw information, deeper analysis, and visual data tools to educate people on biotechnology.

BioMap is a new media company (versus "old media") founded in 2018 by Isaac Larkin, Christopher Norys, and Maxx Chatsko. Founded as a public benefit company, the platform aims to build and encourage a more open and distributed biotech sector through creative projects, independent analysis, data tools, and partnerships.

Arzeda is a biotechnology company designing custom organisms using knowledge of synthetic biology, cellular agricultural, and computational biology technologies for the production of specialty and bulk chemical products. Arzeda uses theirits own proprietary software technologies for computational enzyme design, protein optimization, and metabolic engineering to create organisms capablethat ofare chemicalintended productionto produce chemicals on an industrial scale. The company is located in Seattle, Washington and was founded in 2008 by Eric Althoff, David Baker, Daniela Grabs, and Alexandre Zanghellini.

Arzeda uses computer simulations to design up to 10^37 possible enzymes capable of performing a certain biochemical function. TheirIts computational system then tests the potential enzymes under multiple conditions through simulations in an attempt to see which enzyme design is optimal for specific cases. The best candidates are then selected to be made in the lab and tested in real-world settings.

Azeda uses theirits in-house software for protein optimization called Archytas. Archytas is capable of identifying high energy areas within protein structures and come up with designs that improve enzyme function and/or add or subtract biochemical properties of an enzyme.

Arzeda combines theirits enzyme design and protein optimization techniques with their bioengineering tools to create novel metabolic pathways. TheirIts metabolic engineering system is compromised ofcomprises three steps: identify existing enzymes with the desired properties, re-engineer enzymes to perform desired function, and design new enzymes capable of novel biological functions. By combining these three processes Arzeda is able to design completely new metabolic pathways capable of producing desired products.

On December 8, 2009 Arzeda received a $149,000 grant from the National Science Foundation on December 8, 2009 for a 6-monthsix-month contract to try and create an enzyme capable of producing butadiene.

On December 12, 2013 Arzeda recieved an undisclosed amount of grant funding from the Advanced Research Projects Agency - Energy division(ARPA-E) in conjunction with the University of Washington for the development of a bioreactor system with the ability to convert methane to methanol.

On July 20, 2017 Arzeda completed theirits Series-A funding round raising $12,000,000 from OS Fund (lead investor), Bioeconomy Capital, Washington Research Foundation, Sustainable Conversion Ventures, and Conversion Ventures.

On July 14, 2009 Arzeda announced theirits first partnership agreement. TheyIt will be partnering up with Dupont's business Pioneer Hi-Bred to increase agricultural productivity through the creation of more efficient crop strains such as corn, soybeans, rice, cotton, and canola. DuPont will have ownership and rights to anything produced during the collaboration.

Arzeda and INVISTA announced they will be partnering up on February 6, 2013. The two companies agreed to collaborate on the development of technologies which can help enable the creation of new bio-derived processes. INVISTA provides their knowledge in the fields of biotechnology, chemicals, and catalysis for integration into Arzeda's software platforms in hopes of accelerating technological development for both companies.

On February 6, 2013 Arzeda announced a partnership with INVISTA. The two companies agreed to collaborate on the development of technologies which can help enable the creation of new bio-derived processes. INVISTA will provide knowledge in the fields of biotechnology, chemicals, and catalysis for integration into Arzeda's software platforms in hopes of accelerating technological development for both companies.

On November 11, 2015 Arzeda announced theira partnership with Stratos Genomics, a biotechnology company developing DNA sequencing technologies, on November 11, 2015. Stratos Genomcs hopes to leverage the software, enzyme engineering, and metabolic bioengineering technologies of Arzeda to advance theirits own "Sequence by Expansion" (SBX) technology. SBX is an enzyme enabled rapid prototyping system for the construction of single molecule DNA sequences. Arzeda will aid Stratos Genomics in making enzymes that improve upon enzymes being used in SBX technology.

On February 16, 2016 Mitsubishi Rayon announced theyit will be working with Arzeda on February 16, 2016 to improve the process of producing a specific chemical building block they useused in several applications. Arzeda is using theirits Archytas protein design software and Mitsubishi Rayon will be offering their expertise in process development and industrialization. The general manager of Mitsubishi Rayon's research and development administration department had the following to say about the Arzeda partnership, “"Through our own experience and expertise, as well as with innovative technology like Arzeda’s, Mitsubishi Rayon can meet the growing global demand for a range of products in a sustainable manner."

On March 21, 2016 Arzeda and Zymergen announced a multi-year deal to work together on developing new strains of organisms capable of manufacturing valuable molecules and materials. Arzeda is offering Zymergen access to theirits metabolic bioengineering, protein optimization, and enzyme design software and technologies; and Zymergen is offering Arzeda access to theirits strain construction technologies. Alexandre Zanghellini, the CEO of Arzeda, said the following about partnering up withthe Zymergenpartnership, "Uniting with Zymergen's innovative strain design platform has the potential to help make our designs a reality. Zymergen's scientists are constantly pushing the envelope in synthetic biology, and we are thrilled to be working with their team."

Lygos received $120k in seed funding from Y combinatorCombinator, FundersClub, Fifty Years, Brainchild Holdings, and 10xGroup.

Lygos Series A raised $13 million led by OS Fund and IA Ventures along with First Round Capital, Y Combinator's Continuity Fund, Fifty Years, Vast venturesVentures, and others.

On June 14, 2018 iGEM announced that it will be partnering with Ginkgo Bioworks. Ginkgo Bioworks committed to being the lead partner for the 2018 International Genetically Engineered Machine Competition. Ginkgo Bioworks has previous history participating in iGEM programs, and is eager to give back to the iGEM community. The CEO of Ginkgo Bioworks, Jason Kelly, said ""As early graduates ourselves, we're humbled to now be in a position where we can give back in such a meaningful way to a partner that shares our values on technology, responsibility, and local action."

According to Wired magazine, in 2016 Illumina's DNA sequencing machines perform 90% of global DNA sequencing. The director of global public relations for illuminaIllumina in 2016 told reporters, "We are at a tipping point in genomics, where a broad community of scientists and researchers continue to translate the potential of the genome from science to discoveries and applications" and believes DNA sequencing technologies made by illuminaIllumina will continue to be in high demand around the world well into the future.

The Open Track includes all other tracks from previous years, except for Software, including Hardware, Measurement, and Art & Design, as well as other projects in Human Practices.

Individuals from industry and academia volunteer to judge the iGEM Competition each year. They score teams on various metrics including the quality of the Wiki, final presentation, and poster, as well as the technical accomplishments of the project itself. There are also track-specific scoring rubrics.

The iGEM Competition has grown from five teams in 2004 to 310 in 2017.The iGEM Foundation states itthe competition has over 30,000 alumni, but this number is likely an overestimate that includes double counting of individuals who have participated in multiple years.

The Open Track includes all tracks from previous years, except for Software, that do not use DNA or parts from the registry. The Open Track includesincluding Hardware, Measurement, and Art & Design, as well as other projects in Human Practices.

The Open Track includes all tracks from previous years, except for Software, that do not use DNADNA or parts from the registry. The Open Track includes Hardware, Measurement, and Art & Design, as well as other projects in Human Practices.

However, teams also compete for awards on top of medals. These include Track Awards (the top team in each track), Special Prizes (such as Best Wiki or Best Education & Public Engagement), and the Grand Prize (the top overall teams at each level). Judges decide the top three teams at the undergraduate level, the top two teams at the overgraduate level, and the top team at the high school level. The iGEM Competition begins each February with team formation and fundraising efforts, culminating at the iGEM Giant Jamboree in BostonBoston, Massachusetts in late October or early November.